4P-Pharma secures a total capital of EUR 15Mln in second closing
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors. With this funding, 4P-Pharma’s shareholders renew their confidence in the company’s drug regeneration model for untreated serious diseases. They […]
